MARKET

GTBP

GTBP

Gt Biopharma Inc
NASDAQ
0.4400
+0.0100
+2.33%
Pre Market: 0.4488 +0.0088 +2.00% 08:15 06/30 EDT
OPEN
0.4500
PREV CLOSE
0.4300
HIGH
0.4575
LOW
0.4206
VOLUME
12.43K
TURNOVER
0
52 WEEK HIGH
3.730
52 WEEK LOW
0.2610
MARKET CAP
15.87M
P/E (TTM)
-0.0360
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GTBP last week (0622-0626)?
Weekly Report · 1d ago
Weekly Report: what happened at GTBP last week (0615-0619)?
Weekly Report · 06/22 09:11
GT Biopharma announces annual shareholder meeting
PUBT · 06/18 20:46
Weekly Report: what happened at GTBP last week (0608-0612)?
Weekly Report · 06/15 09:11
GT Biopharma Lowers Stockholder Quorum to One-Third
TipRanks · 06/12 23:02
GT Biopharma lowers shareholder meeting quorum threshold to one-third of outstanding shares
PUBT · 06/12 20:31
Weekly Report: what happened at GTBP last week (0601-0605)?
Weekly Report · 06/08 09:10
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 06/01 12:06
More
About GTBP
GT Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology therapeutic products based on its proprietary Tri-specific Killer Engager (TriKE) natural killer (NK) cell engager platform. Its TriKE platform is designed to harness and enhance the cancer-killing abilities of a patient’s immune system’s natural killer cells. Its product candidate pipeline includes GTB-3550, GTB-3650, GTB-5550, GTB-7550, GTB-6550, GTB-1050, and other product candidates. GTB-3550 is a TriKE comprised of two single-chain variable fragments (scFv) composed of the variable regions of the heavy and light chains of anti-CD16 and anti-CD33 antibodies and a modified form of IL-15. GTB-3650 is a TriKE which targets CD33 on the surface of myeloid leukemias. The Company also has a worldwide license agreement with the University of Minnesota to further develop and commercialize therapies using TriKE technology.

Webull offers GT Biopharma Inc stock information, including NASDAQ: GTBP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GTBP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GTBP stock methods without spending real money on the virtual paper trading platform.